Fideres’s research on generic drug pricing was covered today by Bloomberg. The research analysed price increases for individual generic drugs among different manufacturers and the timings of these price increases. The coverage of Fideres’s work comes as the Department of Justice continues their investigation into alleged collusion by drug manufacturers.
The full article can be found here.
